Scholarlink

<p>Green tea polyphenols (GTPP) are known for their antioxidant and anticancer activities but suffer from low bioavailability due to instability in the gastrointestinal environment. This study aimed to enhance the oral delivery of GTPP by encapsulating epicatechin, epigallocatechin gallate (EGCG), catechin, gallic acid, theaflavin, and caffeine into iron oxide chitosan nanoparticles (IOCHNP). Using high performance liquid chromatography (HPLC), the release of GTPP was evaluated in vitro and in vivo in both simulated intestinal media and rat’s plasma. GTPP-IOCHNP efficiently encapsulates GTPP, achieving an encapsulation efficiency of 90.9% for catechin and 83.3% for theaflavin. Additionally, less than 8% of GTPP is released in simulated gastric fluid (SGF), while its more readily released in simulated intestinal fluid (SIF) is enhanced, reaching 70% for caffeine. The release of gallic acid and epicatechin followed Higuchi kinetics, catechin followed Korsmeyer-Peppas, and caffeine followed Weibull model, indicating diverse mechanisms of release. The in vivo results demonstrated that GTPP loaded GTPP-IOCHNP significantly enhanced the absorption of GTPP compared to GTPP administered alone (<i>p</i> &lt; 0.05). The bioavailability of EGCG, epicatechin, catechin, gallic acid and theaflavin was improved by approximately 8.5-, 6.5-, 4.8-, 5- and 3.5- fold respectively when delivered using GTPP-IOCHNP as a carrier. These findings highlight the potential of IOCHNP as an efficient oral delivery platform for tea polyphenols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In vitro release kinetics and in vivo plasma exposure of green tea polyphenols and caffeine from iron oxide chitosan nanoparticles

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月20日

查看全文
  • Safaa Al Awawdeh,
  • Nurul Husna Shafie,
  • Amirah Haziyah Ishak,
  • Norhaizan Mohd Esa,
  • Su Peng Loh,
  • Armania Nurdin

摘要

Green tea polyphenols (GTPP) are known for their antioxidant and anticancer activities but suffer from low bioavailability due to instability in the gastrointestinal environment. This study aimed to enhance the oral delivery of GTPP by encapsulating epicatechin, epigallocatechin gallate (EGCG), catechin, gallic acid, theaflavin, and caffeine into iron oxide chitosan nanoparticles (IOCHNP). Using high performance liquid chromatography (HPLC), the release of GTPP was evaluated in vitro and in vivo in both simulated intestinal media and rat’s plasma. GTPP-IOCHNP efficiently encapsulates GTPP, achieving an encapsulation efficiency of 90.9% for catechin and 83.3% for theaflavin. Additionally, less than 8% of GTPP is released in simulated gastric fluid (SGF), while its more readily released in simulated intestinal fluid (SIF) is enhanced, reaching 70% for caffeine. The release of gallic acid and epicatechin followed Higuchi kinetics, catechin followed Korsmeyer-Peppas, and caffeine followed Weibull model, indicating diverse mechanisms of release. The in vivo results demonstrated that GTPP loaded GTPP-IOCHNP significantly enhanced the absorption of GTPP compared to GTPP administered alone (p < 0.05). The bioavailability of EGCG, epicatechin, catechin, gallic acid and theaflavin was improved by approximately 8.5-, 6.5-, 4.8-, 5- and 3.5- fold respectively when delivered using GTPP-IOCHNP as a carrier. These findings highlight the potential of IOCHNP as an efficient oral delivery platform for tea polyphenols.